- £4.59m
- £2.38m
- £6.67m
- 28
- 58
- 41
- 35
2019 September 30th | 2020 September 30th | R2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7.56 | 9.53 | 9.19 | 8.64 | 6.67 |
Cost of Revenue | |||||
Gross Profit | 4.94 | 6.35 | 6.02 | 5.24 | 3.27 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7.2 | 8.68 | 8.07 | 7.74 | 8.1 |
Operating Profit | 0.364 | 0.856 | 1.12 | 0.908 | -1.44 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 0.366 | 0.858 | 1.1 | 0.885 | -1.36 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.432 | 0.952 | 1.51 | 1.03 | -1.18 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.432 | 0.952 | 1.51 | 1.03 | -1.18 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.432 | 0.952 | 1.51 | 1.03 | -1.18 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.009 | 0.02 | 0.03 | 0.021 | -0.024 |